Cargando…
A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment
Our study aimed to develop an immune prognostic signature that could provide accurate guidance for the treatment of esophageal squamous cell cancer (ESCC). By implementing Single-Sample Gene Set Enrichment Analysis (ssGSEA), we established two ESCC subtypes (Immunity High and Immunity Low) in GSE536...
Autores principales: | Gao, Jianyao, Tang, Ting, Zhang, Baohui, Li, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943886/ https://www.ncbi.nlm.nih.gov/pubmed/33718151 http://dx.doi.org/10.3389/fonc.2021.603634 |
Ejemplares similares
-
A novel immunogenomic prognostic signature in lung squamous carcinoma
por: Hou, Jili, et al.
Publicado: (2021) -
Development and Verification of a Prostate Cancer Prognostic Signature Based on an Immunogenomic Landscape Analysis
por: Cheng, Hong, et al.
Publicado: (2021) -
Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer
por: Mao, Chenchen, et al.
Publicado: (2021) -
Hierarchical Clustering of Cutaneous Melanoma Based on Immunogenomic Profiling
por: Yu, Jie, et al.
Publicado: (2020) -
Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling
por: Zhou, Xianghong, et al.
Publicado: (2020)